Featured Research

from universities, journals, and other organizations

Unraveling the mysteries of the natural killer within us

Date:
October 25, 2011
Source:
Monash University
Summary:
Scientists in Australia have discovered more about the intricacies of the immune system in a breakthrough that may help combat viral infections such as HIV. The researchers have discovered more about the critical role Natural Killer cells play in the body's innate immune response.

Professor Jamie Rossjohn.
Credit: Image courtesy of Monash University

Scientists have discovered more about the intricacies of the immune system in a breakthrough that may help combat viral infections such as HIV.

Co-led by Professor Jamie Rossjohn of Monash University and Associate Professor Andrew Brooks from University of Melbourne, an international team of scientists have discovered more about the critical role Natural Killer cells play in the body's innate immune response.

The findings were published in Nature.

Natural Killer cells are a unique type of white blood cell important in early immune responses to tumours and viruses. Unlike most cells of the immune system that are activated by molecules found on the pathogen or tumour, Natural Killer cells are shut down by a group of proteins found on healthy cells.

These de-activating proteins, known as Human Leukocyte Antigens or HLA molecules are absent in many tumours and cells infected with viruses, leaving them open to attack by the Natural Killer cells.

Natural Killer cells recognise the HLA molecules using an inbuilt surveillance system called "Killer cell immunoglobulin-like receptors" (KIR).

Using the Australian Synchrotron, the team determined the three dimensional shape of one of these key KIR proteins, termed KIR3DL1, which binds to a particular HLA molecule.

This pairing is known to play a role in limiting viral replication in people with HIV, slowing the progression of the disease to AIDS.

Professor Rossjohn said that better understanding the structure of KIR proteins may help to develop approaches to better utilise Natural Killer cells to combat viral infection.

"It is only possible to detect proteins, such as KIRs, using extremely high-end equipment. The use of the platform technologies at Monash and the Australian Synchrotron was absolutely essential to this project's success," Professor Rossjohn said.

Professor Brooks said the researchers would use these findings to investigate other KIR molecules.

"Since KIR3DL1 is only a single member of a much larger family of receptors, the study provides key insight into how Natural Killer cells utilise other members of this important family of receptors to recognise virus-infected cells and tumours." Professor Brooks said.

The five-year project involved international collaborations with researchers from the National Cancer Institute-Frederick, National Institute of Allergy and Infectious Diseases, National Institutes of Health and Cardiff University School of Medicine.

The research was funded by the National Health and Medical Research Council, the Australian Research Council, the Intramural Research Programs of the National Cancer Institute, the National Cancer Institute of Allergy and Infectious Diseases, Medical Research Council (UK) and National Institutes of Health.


Story Source:

The above story is based on materials provided by Monash University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Julian P. Vivian, Renee C. Duncan, Richard Berry, Geraldine M. O’Connor, Hugh H. Reid, Travis Beddoe, Stephanie Gras, Philippa M. Saunders, Maya A. Olshina, Jacqueline M. L. Widjaja, Christopher M. Harpur, Jie Lin, Sebastien M. Maloveste, David A. Price, Bernard A. P. Lafont, Daniel W. McVicar, Craig S. Clements, Andrew G. Brooks, Jamie Rossjohn. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature, 2011; DOI: 10.1038/nature10517

Cite This Page:

Monash University. "Unraveling the mysteries of the natural killer within us." ScienceDaily. ScienceDaily, 25 October 2011. <www.sciencedaily.com/releases/2011/10/111024113138.htm>.
Monash University. (2011, October 25). Unraveling the mysteries of the natural killer within us. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/10/111024113138.htm
Monash University. "Unraveling the mysteries of the natural killer within us." ScienceDaily. www.sciencedaily.com/releases/2011/10/111024113138.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins